Glaukos Corporation is focused on treating glaucoma, a common and potentially blinding eye disease characterized by elevated pressure inside the eye. The Glaukos devices are tiny titanium tubes which are implanted inside the eye via a minimally invasive procedure that increases fluid outflow from the eye. The promise of the technology is that it could be a definitive solution for glaucoma and eliminate the need for most medications.